The analysis included 3,845,171 patients with type 2 diabetes, of whom 15.1% were prescribed a GLP-1 RA, including 6.6% who received dulaglutide, 4.9% who received semaglutide, 4.2% who received liraglutide, and 2.1% who received exenatide
Journal of Human Reproductive Sciences
GLP-1 RA TYPES/NAME BRANDS: Dulaglutide (Trulicity) Exenatide (Byetta, Bydureon) Liraglutide (Victoza, Saxenda) Semaglutide (Ozempic, Wegovy, Rybelsus) Tirzepatide (Mounjaro, Zepbound)
How to Prepare and Perform Your Injection Step by Step A straightforward, calm approach helps anyone inject more smoothly
TFL coverage of GLP-1 drugs that are approved by the Food and Drug Administration (FDA) to treat weight loss (Wegovy, Zepbound, Saxenda, Qsymia, Phentermine, or Contrave) is slated to end Aug